Association of cytokine/costimulatory molecule polymorphism and allograft rejection: a comparative review

References

• Hajeer AH, Hutchinson IV. TNF-alpha gene polymorphism: clinical and biological implications. Microsc Res Tech. 50(3), 216–228 (2000).
   PubMed Web of Science ®Google Scholar
• Suthanthiran M. The importance of genetic polymorphisms in renal transplantation. Curr. Opin. Urol. 10, 71–75 (2000).
   PubMedGoogle Scholar
• Turner DM, Williams DM, Sankaran D, Lazarus M, Sinnott PJ, Hutchinson IV. An investigation of polymorphism in the interleukin-10 gene promoter. Eur. J. Immunogenet. 24, 1–8 (1997).
   PubMedGoogle Scholar
• Ashoor IF, Najafian N. Rejection and regulation: a tight balance. Curr. Opin. Organ Transplant. 17, 1–7 (2012).
   Google Scholar
• Awad MR, Webber S, Boyle G et al. The effect of cytokine gene polymorphisms on pediatric heart allograft outcome. J. Heart. Lung. Transplant. 20(6), 625–630 (2001).
   Google Scholar
• Turner D, Grant SC, Yonan N et al. Cytokine gene polymorphism and heart transplant rejection. Transplantation 64(5), 776–779 (1997).
   Google Scholar
• Densem CG, Hutchinson IV, Yonan N, Brooks NH. Influence of tumor necrosis factor-alpha gene-308 polymorphism on the development of coronary vasculopathy after cardiac transplantation. J. Heart. Lung. Transplant 20(12), 1265–1273 (2001).
   Google Scholar
• Densem CG, Ray M, Hutchinson IV, Yonan N, Brooks NH. Interleukin-6 polymorphism: a genetic risk factor for cardiac transplant related coronary vasculopathy? J. Heart. Lung. Transplant 24(5), 559–565 (2005).
   Google Scholar
• Domanski L, Rozanski J, Florczak M, Dabrowska-Zamojcin E, Dutkiewicz G, Gawronska-Szklarz B. Pawlik A. IL-2 and TNF-alpha promoter polymorphisms in patients with acute kidney graft rejection Transplant Proc. 37(5), 2041–2043 (2005).
   Google Scholar
• Sankaran D, Asderakis A, Ashraf S, Roberts IS, Short CD, Dyer PA, Sinnott PJ, Hutchinson IV. Cytokine gene polymorphisms predict acute graft rejection following renal transplantation. Kidney Int. 56(1), 281–288 (1999).
   Google Scholar
• Abdallah AN, Cucchi-Mouillot P, Biteau N, Cassaigne A, Haras D, Iron A. Analysis of the polymorphism of the tumor necrosis factor[TNF] gene and promoter and of circulating TNF-α levels in heart transplant patients suffering or not suffering from severe rejection. Eur. J. Immunogenet 26, 249–255 (1999).
   Google Scholar
• Marshall SE, McLaren AJ, Haldar NA, Bunce M, Morris PJ, Welsh KI. The impact of recipient cytokine genotype on acute rejection after renal transplantation. Transplantation. 70(10),1485–91 (2000).
   Google Scholar
• Girnita D M, Burckart G, Zeevi A. Effect of cytokine and pharmacogenomic genetic polymorphisms in transplantation. Curr. Opin. Immunol. 20(5),614–625 (2008).
   Google Scholar
• Snyder LD, Hartwig MG, Ganous T et al. Cytokine gene polymorphisms are not associated with bronchiolitis obliterans syndrome or survival after lung transplant. J. Heart. Lung. Transplant. 25(11),1330–1335 (2006).
   Google Scholar
• Azarpira N, Aghdaie MH, Geramizadeh B et al. Cytokine gene polymorphisms in renal transplant recipients. Exp. Clin. Transplant. 4(2),528–531 (2006).
   Google Scholar
• Brabcova I, Petrasek J, Hribova P, Hyklova K, Bartosova K, Lacha J, Viklický O. Genetic variability of major inflammatory mediators has no impact on the outcome of kidney transplantation. Transplantation. 84(8),1037–1044 (2007).
   Google Scholar
• Breulmann B, Bantis C, Siekierka M et al. Influence of cytokine genes polymorphisms on long-term outcome in renal transplantation. Clin. Transplant. 21(5), 615–621 (2007).
   Google Scholar
• Alakulppi NS, Kyllönen LE, Partanen J, Salmela KT, Laine JT. Lack of association between thrombosis-associated and cytokine candidate gene polymorphisms and acute rejection or vascular complications after kidney transplantation. Nephrol. Dial Transplant. 23(1), 364–368 (2008).
   Google Scholar
• Goldfarb-Rumyantzev AS, Naiman N. Genetic prediction of renal transplant outcome. Curr. Opin. Nephrol. Hypertens. 17(6), 573–579 (2008).
   PubMed Web of Science ®Google Scholar
• Tinckam K, Rush D, Hutchinson I, Dembinski I, Pravica V, Jeffery J, Nickerson P. The relative importance of cytokine gene polymorphisms in the development of early and late acute rejection and six-month renal allograft pathology. Transplantation 79(7), 836–841 (2005).
   Google Scholar
• Manchanda PK, Mittal RD. Analysis of cytokine gene polymorphisms in recipient's matched with living donors on acute rejection after renal transplantation. Mol Cell Biochem 311(1–2), 57–65 (2008).
   Google Scholar
• Nikolova PN, Ivanova MI, Mihailova SM et al. Cytokine gene polymorphism in kidney transplantation--impact of TGF-beta 1, TNF-alpha and IL-6 on graft outcome. Transplant Immunol 18(4),344–348 (2008).
   Google Scholar
• De Serres SA, Vadivel N, Mfarrej BG et al. Monocyte-secreted inflammatory cytokines are associated with transplant glomerulopathy in renal allograft recipients. Transplantation. 91(5), 552–559 (2011).
   Google Scholar
• Fernandes H, Koneru B, Fernandes N, Hameed M, Cohen MC, Raveche E, Cohen S. Investigation of promoter polymorphisms in the tumor necrosis factor-alpha and interleukin-10 genes in liver transplant patients. Transplantation. 73(12),1886–1891 (2002).
   Google Scholar
• Bathgate AJ, Pravica V, Perrey C, Therapondos G, Plevris JN, Hayes PC, Hutchinson IV. The effect of polymorphisms in tumor necrosis factor-alpha, interleukin-10, and transforming growth factor-beta1 genes in acute hepatic allograft rejection. Transplantation 69(7),1514–1517 (2000).
   Google Scholar
• Freeman RB Jr, Tran CL, Mattoli J et al. Tumor necrosis factor genetic polymorphisms correlate with infections after liver transplantation. NEMC TNF Study Group. New England Medical Center Tumor Necrosis Factor. Transplantation 67(7), 1005–1010 (1999).
   Google Scholar
• Sahoo S, Kang S, Supran S, Saloman R, Wolfe H, Freeman RB. Tumor necrosis factor genetic polymorphisms correlate with infections after renal transplantation. Transplantation 69(5), 880–884 (2000).
   Google Scholar
• Warle MC, Metselaar HJ, Hop WC, Tilanus HW. Cytokine gene polymorphisms and acute liver graft rejection: a meta-analysis. Liver Transpl 11(1), 19–26 (2005).
   Google Scholar
• Kimball P, Baker M, Fisher RA. Allograft TNFbeta and IL-16 polymorphisms influence HCV recurrence and severity after liver transplantation. Liver Transpl 12(2), 247–252 (2006).
   Google Scholar
• Dickinson AM, Harrold JL, Cullup H. Haematopoietic stem cell transplantation: can our genes predict clinical outcome? Expert. Rev. Mol. Med. 9(29), 1–19 (2007).
   Google Scholar
• Viel DO, Tsuneto LT, Sossai CR et al. IL-2 and TNFA gene polymorphisms and the risk of graft-versus-host disease after allogeneic haematopoietic stem cell transplantation. Scand J Immunol 66(6), 703–10 (2007).
   Google Scholar
• Azarpira N, Aghdai MH, Raisjalali GA, Darai M, Tarahi MJ. Influence of recipient and donor IL-10, TNFA and INFG genotypes on the incidence of acute renal allograft rejection. Mol. Biol. Rep. 36(6), 1621–1626 (2009).
   Google Scholar
• Asadullah K, Sterry W, Volk HD. Interleukin-10 therapy—Review of a new approach. Pharmacol. Rev. 55, 241–269 (2003).
   PubMed Web of Science ®Google Scholar
• Thakkinstian A, Dmitrienko S, Gerbase-Delima M et al. Association between cytokine gene polymorphisms and outcomes in renal transplantation: a meta-analysis of individual patient data. Nephrol. Dial. Transplant. 23(9), 3017–3023 (2008).
   PubMed Web of Science ®Google Scholar
• Girnita DM, Brooks MM, Webber SA et al. Genetic polymorphisms impact the risk of acute rejection in pediatric heart transplantation: a multi-institutional study. Transplantation 85(11):1632–1639 (2008).
   Google Scholar
• Marshall SE, Welsh KI. The role of cytokine polymorphisms in rejection after solid organ transplantation. Genes. Immun. 2(6), 297–303 (2001).
   Google Scholar
• Girnita DM, Webber SA, Ferrell R et al. Disparate distribution of 16 candidate single nucleotide polymorphisms among racial and ethnic groups of pediatric heart transplant patients. Transplantation 82(12), 1774–1780 (2006).
   Google Scholar
• Akalin E, Murphy B. Gene polymorphisms and transplantation. Curr. Opin. Immunol 13, 572–576 (2001).
   PubMed Web of Science ®Google Scholar
• Pelletier R, Pravica V, Perrey C, Xia D, Ferguson RM, Hutchinson I, Orosz C. Evidence for a genetic predisposition towards acute rejection after kidney and simultaneous kidney-pancreas transplantation. Transplantation 27, 674–680(2000).
   Google Scholar
• Regateiro FS, Howie D, Cobbold SP, Waldmann H. TGF-β in transplantation tolerance. Curr. Opin. Immunol. 23(5), 660–669 (2011).
   Google Scholar
• Shilling RA, Wilkes DS. Role of Th17 cells and IL-17 in lung transplant rejection. Semin Immunopathol. 33(2), 129–134 (2011).
   Google Scholar
• Cambien F, Ricard S, Troesch A et al. Polymorphisms of the transforming growth factor-beta 1 gene in relation to myocardial infarction and blood pressure. The Etude Cas-Te´moin de l’Infarctus du Myocarde (ECTIM) Study. Hypertension 28, 881–887 (1996).
   PubMed Web of Science ®Google Scholar
• Awad MR, El-Gamel A, Hasleton P, Turner DM, Sinnott PJ, Hutchinson IV. Genotypic variation in the transforming growth factor-beta1 gene: association with transforming growth factorbeta1 production, fibrotic lung disease, and graft fibrosis after lung transplantation. Transplantation 66, 1014–20 (1998).
   PubMed Web of Science ®Google Scholar
• Aziz T, Hasleton P, Hann AW, Yonan N, Deiraniya A, Hutchinson IV. Transforming growth factor beta in relation to cardiac allograft vasculopathy after heart transplantation. J. Thorac. Cardiovasc. Surg 119, 700–708 (2000).
   Google Scholar
• Densem CG, Hutchinson IV, Cooper A, Yonan N, Brooks NH. Polymorphism of the transforming growth factor-beta 1 gene correlates with the development of coronary vasculopathy following cardiac transplantation. J. Heart. Lung. Transplant 19,551–556 (2000).
   PubMed Web of Science ®Google Scholar
• Holweg CT, Baan CC, Balk AH, Niesters HG, Maat AP, Mulder PM, Weimar W. The transforming growth factor-beta1 codon 10 gene polymorphism and accelerated graft vascular disease after clinical heart transplantation. Transplantation 71, 1463–1467 (2001).
   PubMed Web of Science ®Google Scholar
• Hueso M, Navarro E, Moreso F et al. Relationship between subclinical rejection and genotype, renal messenger RNA, and plasma protein transforming growth factor-beta1 levels. Transplantation 81(10), 1463–1466 (2006).
   Google Scholar
• Berndt SI, Huang WY, Chatterjee N et al. Transforming growth factor beta 1 (TGFB1) gene polymorphisms and risk of advanced colorectal adenoma. Carcinogenesis. 28(9),1965–1970 (2007).
   Google Scholar
• Gómez-Mateo J, Marin L, López-Alvarez MR et al. TGF-beta1 gene polymorphism in liver graft recipients. Transplant. Immunol 17(1), 55–57 (2006).
   Google Scholar
• Müller-Steinhardt M, Härtel C, Müller B, Kirchner H, Fricke L. The interleukin-6 −174 promoter polymorphism is associated with long-term kidney allograft survival. Kidney. Int. 62(5), 1824–1827 (2002).
   Google Scholar
• Poole KL, Gibbs PJ, Evans PR, Sadek SA, Howell WM. Influence of patient and donor cytokine genotypes on renal allograft rejection: evidence from a single centre study. Transplant. Immunol. 8(4), 259–265 (2001).
   Google Scholar
• Marshall SE, McLaren AJ, McKinney EF, Bird TG, Haldar NA, Bunce M, Morris PJ, Welsh KI. Donor cytokine genotype influences the development of acute rejection after renal transplantation. Transplantation 71(3), 469–476 (2001).
   Google Scholar
• Karimi MH, Daneshmandi S, Pourfathollah AA et al. A study of the impact of cytokine gene polymorphism in acute rejection of renal transplant Mol. Biol. Rep 39, 509–515 (2012).
   PubMed Web of Science ®Google Scholar
• Karimi MH, Daneshmandi S, Pourfathollah AA et al. Association of IL-6 promoter and IFN-γ gene polymorphisms with acute rejection of liver transplantation. Mol. Biol. Rep 38, 4437–4443 (2011).
   Google Scholar
• Abadja F, Sarraj B, Ansari MJ. Significance of T helper 17 immunity in transplantation. Curr. Opin. Organ Transplant. 17(1), 8–14 (2012).
   PubMedGoogle Scholar
• Aggarwal S, Gurney AL. IL-17: prototype member of an emerging cytokine family. J Leukoc Biol. 71(1), 1–8 (2002).
   PubMed Web of Science ®Google Scholar
• Toy D, Kugler D, Wolfson M, Vanden Bos T, Gurgel J, Derry J, Tocker J, Peschon J. Cutting edge: interleukin 17 signals through a heteromeric receptor complex. J Immunol. 177(1), 36–39 (2006).
   PubMed Web of Science ®Google Scholar
• Ouyang W, Kolls JK, Zheng Y. The biological functions of T helper 17 cell effector cytokines in inflammation. Immunity. 28(4),454–467 (2008). Review.
   PubMed Web of Science ®Google Scholar
• Ishigame H, Kakuta S, Nagai T, Kadoki M, Nambu A, Komiyama Y, Fujikado N, Tanahashi Y, Akitsu A, Kotaki H, Sudo K, Nakae S, Sasakawa C, Iwakura Y. Differential roles of Interleukin-17A and −17F in host defense against mucoepithelial bacterial infection and allergic responses. Immunity. 30(1), 108–119 (2009).
   PubMed Web of Science ®Google Scholar
• Espinoza JL, Takami A, Nakata K et al. A genetic variant in the IL-17 promoter is functionally associated with acute graft-versus-host disease after unrelated bone marrow transplantation. PLoS One 6(10), e26229 (2010).
   Google Scholar
• Espinoza JL, Takami A, Onizuka M et al. A single nucleotide polymorphism of IL-17 gene in the recipient is associated with acute GVHD after HLA-matched unrelated BMT. Bone Marrow Transplant. 46(11), 1455–1463(2011).
   Google Scholar
• Karimi MH, Hejr S, Geramizadeh B, Nikeghbalian S, Kamali-sarvestani E, Yaghobi R. Study of the relationships between IL-23R, IL-17, IL-21 polymorphisms and serum level of IL-17, IL-21 with acute graft rejection in Iranian liver transplant recipients. 26(3), 201–206 (2013)
   Google Scholar
• Gabay C. IL-6 and chronic inflammation. Arthritis. Res. Ther. 8 2, S3 (2006).
   PubMed Web of Science ®Google Scholar
• Thakkinstian A, Dmitrienko S, Gerbase-Delima M et al. Association between cytokine gene polymorphisms and outcomes in renal transplantation: a meta-analysis of individual patient data. Nephrol. Dial. Transplant. 23(9), 3017–3023 (2008).
   PubMed Web of Science ®Google Scholar
• Marder B, Schroppel B, Murphy B. Genetic variability and transplantation. Curr. Opin. Urol. 13, 81–89 (2003).
   Google Scholar
• Karabon L, Wysoczanska B, Bogunia-Kubik K, Suchnicki K, Lange A. IL-6 and IL-10 promoter gene polymorphisms of patients and donors of allogeneic sibling hematopoietic stem cell transplants associate with the risk of acute graft-versus-host disease. Human Immunol 66(6), 700–710 (2005).
   Google Scholar
• Tambur AR, Ortegel JW, Ben-Ari Z et al. Role of cytokine gene polymorphism in hepatitis c recurrence and allograft rejection among liver transplant recipients. Transplantation 71, 1475–1480 (2001).
   Google Scholar
• Daher S, Shulzhenko N, Morgun A, Mattar R, Rampim GF, Camano L, DeLima MG. Associations between cytokine gene polymorphisms and recurrent pregnancy loss. J. Reprod. Immunol. 58, 69–77 (2003).
   PubMed Web of Science ®Google Scholar
• Dabora SL, Roberts P, Nieto A et al. Association between a high-expressing interferon-gamma. allele and a lower frequency of kidney angiomyolipomas in TSC2 patients. Am. J. Hum. Genet. 71, 750–758 (2002).
   PubMed Web of Science ®Google Scholar
• Lu KC, Jaramillo A, Lecha RL et al. Interleukin-6 and interferon-gamma gene polymorphisms in the development of bronchiolitis obliterans syndrome after lung transplantation. Transplantation 74(9),1297–1302 (2002).
   Google Scholar
• Brabcova I, Petrasek J, Hribova P et al. Genetic variability of major inflammatory mediators has no impact on the outcome of kidney transplantation. Transplantation 84(8), 1037–1044 (2007).
   Google Scholar
• Girnita DM, Burckart G, Zeevi A. Effect of cytokine and pharmacogenomic genetic polymorphisms in transplantation. Curr Opin Immunol. 20(5), 614–25 (2008).
   Google Scholar
• Horie Y, Kitaichi N, Takemoto Y et al. Polymorphism of IFN-gamma gene and Vogt-Koyanagi-Harada disease. Mol. Vis. 13, 2334–2338 (2007).
   PubMed Web of Science ®Google Scholar
• Pravica V, Perrey C, Stevens A, Lee JH, Hutchinson IV. A single nucleotide polymorphism in the first intron of the human IFN-gamma gene: absolute correlation with a polymorphic CA microsatellite marker of high IFN-gamma production. Hum. Immunol. 61(9), 863–866 (2000).
   PubMed Web of Science ®Google Scholar
• Awad M, Pravica V, Perrey C, El Gamel A, Yonan N, Sinnott PJ, Hutchinson IV. CA repeat allele polymorphism in the first intron of the human interferon-gamma gene is associated with lung allograft fibrosis. Hum Immunol. 60(4), 343–346 (1999).
   Google Scholar
• Ghaderi A. CTLA4 gene variants in autoimmunity and cancer: a comparative review. Iran. J. Immunol. 8, 127–149(2011).
   PubMedGoogle Scholar
• Pérez-García A, De la Cámara R, Román-Gómez J et al. CTLA-4 polymorphisms and clinical outcome after allogeneic stem cell transplantation from HLA-identical sibling donors. Blood 110(1),461–467 (2007).
   PubMed Web of Science ®Google Scholar
• Hudson LL, Rocca K, Song YW, Pandey JP. CTLA-4 gene polymorphisms in systemic lupus erythematosus: a highly significant association with a determinant in the promoter region. Hum Genet. 111, 452–5 (2002).
   PubMed Web of Science ®Google Scholar
• Guo Y, Fan Y, Qiu J, Liu Y, Gao J, Guo F. Polymorphisms in CTLA4 influence incidence of drug-induced liver injury after renal transplantation in Chinese recipients. PLoS One. 7(12), e51723 (2012).
   Google Scholar
• Karimi MH, Motazedian M, Abedi F, Yaghobi R, Geramizadeh B, molecule genes with outcome of liver transplant in Iranian patients. Gene 504(1), 127–132 (2012).
   Google Scholar
• Kouki T, Sawai Y, Gardine CA, Fisfalen ME, Alegre ML, DeGroot LJ. CTLA-4 gene polymorphism at position 49 in exon 1 reduces the inhibitory function of CTLA-4 and contributes to the pathogenesis of Graves’ disease. J Immunol. 165, 6606–6611 (2000).
   PubMed Web of Science ®Google Scholar
• Gough SC, Walker LS, Sansom DM. CTLA4 gene polymorphism and autoimmunity. Immunol Rev. 204, 102–115 (2005).
   PubMed Web of Science ®Google Scholar
• Slavcheva E, Albanis E, Jiao Q, Tran H et al. Cytotoxic T-lymphocyte antigen 4 gene polymorphisms and susceptibility to acute allograft rejection. Transplantation. 72(5), 935–940 (2001).
   PubMedGoogle Scholar
• Sun T, Zhou Y, Yang M et al. Functional genetic variations in cytotoxic T-lymphocyte antigen 4 and susceptibility to multiple types of cancer. Cancer Res 68,7025–7034 (2008).
   PubMed Web of Science ®Google Scholar
• Gendzekhadze K, Rivas-Vetencourt P, Montano RF. Risk of adverse post-transplant events after kidney allograft transplantation as predicted by CTLA-4 +49 and TNF-alpha −308 single nucleotide polymorphisms: a preliminary study. Transpl Immunol. 16, 194–199 (2006).
   PubMed Web of Science ®Google Scholar
• Krichen H, Sfar I, Jendoubi-Ayed S. Genetic polymorphisms of immunoregulatory proteins in acute renal allograft rejection. Transplant Proc. 41, 3305–3307 (2009).
   Google Scholar
• Kusztal M, Kościelska-Kasprzak K, Drulis-Fajdasz D et al. The influence of CTLA-4 gene polymorphism on long-term kidney allograft function in Caucasian recipients. Transpl Immunol. 23, 121–124 (2010).
   PubMed Web of Science ®Google Scholar
• Azarian M, Busson M, Lepage V et al. Donor CTLA-4 +49 A/G*GG genotype is associated with chronic GVHD after HLA-identical haematopoietic stem-cell transplantations. Blood. 110, 4623–4624 (2007).
   PubMed Web of Science ®Google Scholar
• Piccioli P, Balbi G, Serra M et al. CTLA-4 +49A>G polymorphism of recipients of HLA-matched sibling allogeneic stem cell transplantation is associated with survival and relapse incidence. Ann. Hematol. 89, 613–618 (2010).
   PubMed Web of Science ®Google Scholar
• Kim HJ, Jeong KH, Lee SH et al. Polymorphisms of the CTLA4 gene and kidney transplant rejection in Korean patients. Transpl. Immunol. 24(1), 40–44 (2010).
   PubMedGoogle Scholar
• Azarpira N, Malekhosseini SA, Aghdaie MH, Daraie M. CTLA4 CT60 A/G gene polymorphism in liver transplant recipients. Exp. Clin. Transplant. 8(3), 210–213 (2010).
   Google Scholar
• Muro M, Rojas G, Botella C et al. CT60 A/G marker of the 3’-untranslated region of the CTLA4 gene and liver transplant. Transpl. Immunol. 18(3),246–249 (2008).
   Google Scholar
• Tapirdamaz O, Pravica V, Metselaar HJ et al. Polymorphisms in the T cell regulatory gene cytotoxic T lymphocyte antigen 4 influence the rate of acute rejection after liver transplantation. Gut 55(6), 863–868 (2006).
   PubMedGoogle Scholar
• Pérez-García A, Brunet S, Berlanga JJ et al. CTLA-4 genotype and relapse incidence in patients with acute myeloid leukemia in first complete remission after induction chemotherapy. Leukemia 23, 486–491 (2009).
   PubMed Web of Science ®Google Scholar
• Vannucchi AM, Guidi S, Guglielmelli P et al. Significance of CTLA-4 and CD14 genetic polymorphisms in clinical outcome after allogeneic stem cell transplantation. Bone Marrow Transplant. 40, 1001–1002 (2007).
   Google Scholar
• Deichmann K, Heinzmann A, Bruggenolte E, Forster J, Kuehr J. An Mse I RFLP in the human CTLA4 promotor. Biochem. Biophys. Res. Commun. 225, 817–818 (1996).
   PubMed Web of Science ®Google Scholar
• Marín LA, Moya-Quiles MR, Miras M et al. Evaluation of CD86 gene polymorphism at +1057 position in liver transplant recipients. Transpl Immunol. 15(1), 69–74 (2005).
   Google Scholar
• Dmitrienko S, Hoar DI, Balshaw R, Keown PA. Immune response gene polymorphisms in renal transplant recipients. Transplantation 80, 1773–1782 (2005).
   PubMed Web of Science ®Google Scholar
• Haimila K, Turpeinen H, Alakulppi NS, Kyllönen LE, Salmela KT, Partanen J. Association of genetic variation in inducible costimulator gene with outcome of kidney transplantation. Transplantation 87,393–396 (2009).
   PubMedGoogle Scholar
• Li XC, Rothstein DM, Sayegh MH. Costimulatory pathways in transplantation: challenges and new developments. Immunol Rev. 229, 271–293 (2009).
   PubMed Web of Science ®Google Scholar
• Durrbach A, Francois H, Jacquet A, Beaudreuil S, Charpentier B. Co-signals in organ transplantation. Curr. Opin. Organ Transplant. 15;474–480 (2010).
   Google Scholar
• Ozkaynak E, Gao W, Shemmeri N et al. Importance of ICOS-B7RP-1 costimulation in acute and chronic allograft rejection. Nat. Immunol 2(7), 591–596 (2001).
   PubMed Web of Science ®Google Scholar
• Wu J, Tang JL, Wu SJ, Lio HY, Yang YC. Functional polymorphism of CTLA-4 and ICOS genes in allogeneic hematopoietic stem cell transplantation. Clin. Chim. Acta. 403(1-2), 229–233 (2009).
   PubMed Web of Science ®Google Scholar
• Ebadi P, Karimi MH, Tahoori MT et al. Polymorphisms of the programmed cell death 1 and ICOS genes and kidney transplant rejection in Iranian patients. African J Microbiol Res 6(41), 6918–6923 (2012).
   Google Scholar
• Karimi MH, Motazedian M, Geramizadeh B et al. Association of the co-stimulatory molecules polymorphisms with CMV infection in liver transplant recipients. Int J Organ Transplant Med 2(4), 171–177 (2011).
   Google Scholar
• Xiao H, Cao W, Lai X et al. Immunosuppressive cytokine gene polymorphisms and outcome after related and unrelated hematopoietic cell transplantation in a Chinese population. Biol Blood Marrow Transplant. 17(4), 542–549 (2011).
   PubMed Web of Science ®Google Scholar
• Wang L, Han R, Hancock WW. Programmed cell death 1 (PD-1) and its ligand PD-L1 are required for allograft tolerance. Eur. J. Immunol. 37(10), 2983–2990 (2007).
   Google Scholar
• Eagar TN, Karandikar NJ, Bluestone JA, Miller SD. The role of CTLA-4 in induction and maintenance of peripheral T cell tolerance. Eur. J. Immunol 32, 972–981 (2002).
   PubMed Web of Science ®Google Scholar
• Anderson MS, Bluestone JA. The NOD mouse: a model of immune dysregulation. Annu. Rev. Immunol 23, 447–485 (2005).
   PubMed Web of Science ®Google Scholar
• Chatenoud L. CD3-specific antibody-induced active tolerance: from bench to bedside. Nat. Rev. Immunol 3,123–132 (2003).
   PubMed Web of Science ®Google Scholar
• Wang Q, Ye D, Yin J, Li X, Zhang G, Zhang Y, Zhang X. Programmed cell death 1 genotypes are associated with susceptibility to systemic lupus erythematosus among Chinese. Arch. Dermatol. Res. 300(2), 91–93 (2008).
   Google Scholar
• Prokunina LC, Castillejo-Lopez F, Oberg I et al. A regulatory polymorphism in PDCD1 is associated with susceptibility to systemic lupus erythematosus in humans. Nat. Genetics 32, 666–669 (2002).
   PubMed Web of Science ®Google Scholar
• Hoffmann TW, Halimi JM, Büchler M et al. Association between a polymorphism in the human programmed death-1 (PD-1) gene and cytomegalovirus infection after kidney transplantation. J. Med. Genet. 47(1), 54–58 (2010).
   Google Scholar
• Ming ZJ, Hui H, Miao M, Qiu YH, Zhang XG. Polymorphisms in PDCD1 gene are not associated with aplastic anemia in Chinese Han population. Rheumatol. Int. 32, 3107–3112 (2012).
   Google Scholar